Arcturus Therapeutics's total assets for Q2 2025 were $309.27M, a decrease of -6.79% from the previous quarter. ARCT total liabilities were $78.22M for the fiscal quarter, a -20.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.